Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about ANAB

Recent news which mentions ANAB

< Previous 1 2 Next >

Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022

November 01, 2022

AnaptysBio / GSK-Partnered Immuno-Oncology Agent Meets Primary Goal In Lung Cancer Trial

October 05, 2022

HC Wainwright Sees 40% Upside For This Once Battered Stock With Pipeline Turnaround

September 19, 2022

This Analyst Slashes PT On Rent the Runway By Around 43%, Plus JP Morgan Predicts $84 For Oracle

September 13, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2022

September 13, 2022

AnaptysBio Sells Royalty Interest In Cancer Drug For $45M

September 12, 2022

Raymond James Initiates AnaptysBio With ~42% Upside, Despite Trial Setback

September 02, 2022

Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2022

September 01, 2022

AnaptysBio Faces Another Setback For Imsidolimab, Stalls Work In Skin Scarring Indication

September 01, 2022

12 Health Care Stocks Moving In Thursday's Pre-Market Session

September 01, 2022

12 Health Care Stocks Moving In Wednesday's After-Market Session

August 31, 2022

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

June 07, 2022

Stocks That Hit 52-Week Lows On Thursday

June 02, 2022

Stocks That Hit 52-Week Lows On Friday

May 27, 2022

Short Volatility Alert: AnaptysBio, Inc.

May 26, 2022

AnaptysBio's Return On Capital Employed Insights

May 24, 2022

The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates

April 28, 2022

AnaptysBio Posts Topline Data From ANB032 Study In Healthy Volunteers

April 28, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 22, 2022

March 22, 2022

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout

March 22, 2022

AnaptysBio To Discontinue Imsidolimab Development In Moderate-to-Severe Acne

March 15, 2022

The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial

March 15, 2022

12 Health Care Stocks Moving In Monday's After-Market Session

March 14, 2022

AnaptysBio's Return On Capital Employed Insights

March 10, 2022

Recap: AnaptysBio Q4 Earnings

March 07, 2022

Hoth Therapeutics Reports Being Set To Begin Phase 2 Study On First-Of-Its-Kind Skin Toxicity Ointment For Cancer Patients

February 01, 2022

The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children

October 26, 2021

AnaptysBio Reveals Updated Imsidolimab Data In Severe Form Of Psoriasis

October 04, 2021

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline

August 18, 2021

AnaptysBio-Generated Antibody Scores Second FDA Approval For Solid Tumor Indication

August 18, 2021

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.